Home / Investments / Worldwide Clinical Trials

Worldwide Clinical Trials

  • Investment Year:2023
  • Investment Status:Current
  • Transaction Type:Private Sale
  • Worldwide Clinical Trials is a leading full-service global contract research organization (CRO) that provides early and late stage clinical development services to pharmaceutical and biotechnology companies with a focus in neuroscience, oncology, rare diseases, and cardiometabolic and inflammatory therapeutic areas.

    Investment Partner: Chris Anderson
    Operating Partner: Matthew Jennings